title: [Clinical observation on prevention of "jia wei si jun zi tang" from damage of hepatic reserving function after intervention of liver cancer].
abstract: OBJECTIVE
  To observe prevention of "Jia Wei Si Jun Zi Tang" (JWSJZT) from damage of hepatic reserving function after intervention of liver cancer.
  
  
  METHODS
  65 patients with advance stage of liver cancer were randomly into two groups, the control group (regular protective therapy) and the treatment group (regular protective therapy + JWSJZT). There were 33 and 32 cases in the control group and treatment group,respectively. ICGR15 was detected before the first and the second intervention treatment and one month after the second intervention treatment, respectively. ICGR15 change was observed before and after the intervention treatment in the two groups.
  
  
  RESULTS
  ICGR15 was 11.13% +/- 7.28% in the treatment group and 11.81% +/- 7.43% in the control group (P > 0.05) before the first intervention; 18.36% +/- 9.82% in the control group and 12.18% +/- 5.22% in the treatment group, before the second invention treatment (P < 0.05); 19.12% +/- 9.96% in the control group and 12.83% +/- 5.28% in the treatment group one month after the second intervention treatment (P < 0.05).
  
  
  CONCLUSIONS
  The western medicine + JWSJZT group is superior in curative effect to western medicine group.
authors.affiliation: Tumor Hospital, Sun Yat-sen University, Guangzhou 510060.
authors.forename: Bei
authors.initials: B
authors.lastname: Zhang
authors.forename: Guoxian
authors.initials: G
authors.lastname: Huang
authors.forename: Yaqi
authors.initials: Y
authors.lastname: Zhang
authors.forename: Xuxian
authors.initials: X
authors.lastname: Chen
authors.forename: Pili
authors.initials: P
authors.lastname: Hu
authors.forename: Boping
authors.initials: B
authors.lastname: Xu
mesh_terms: D000328:Adult; D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000503:physiopathology; D016461:Chemoembolization, Therapeutic / Q000009:adverse effects; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007288:Inosine / Q000008:administration & dosage / Q000627:therapeutic use*; D008111:Liver Function Tests; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D008517:Phytotherapy
chemical_list: D004365:Drugs, Chinese Herbal; C403259:si-jun-zi-tang; D007288:Inosine